Precision radiation aims to make leukemia transplants safer
NCT ID NCT06209190
Summary
This study tested a new, more targeted form of radiation (TMLI) used to prepare patients for a stem cell transplant for acute lymphoblastic leukemia (ALL). The goal was to see if this method was safe and feasible, aiming to keep the cancer-fighting benefits of radiation while reducing damage to healthy tissues. It involved 14 patients aged 16-45 with ALL who were receiving a transplant from a donor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Andres Gomez
Monterrey, Nuevo León, 64710, Mexico
Conditions
Explore the condition pages connected to this study.